Termination of Registration of a Class of Security Under Section 12(b) (15-12b)
October 30 2017 - 6:10AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 15
CERTIFICATION AND NOTICE OF TERMINATION
OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS
13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.
Commission File Number: 001-36737
NeuroDerm
Ltd.
(Exact name of registrant as specified in
its charter)
Ruhrberg Science Building
3 Pekeris St.
Rehovot 7670212, Israel
+972
(8) 946-2729l
(Address, including zip code, and telephone
number, including area code, of registrant’s principal executive offices)
Ordinary
shares, par value NIS 0.01 per share
(Title of each class of securities covered
by this Form)
None
(Titles of all other classes of securities
for which a duty to file reports under Section 13(a) or 15(d) remains)
Please place an X in the
box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:
|
Rule 12g-4(a)(1)
|
¨
|
|
Rule 12g-4(a)(2)
|
¨
|
|
Rule 12h-3(b)(1)(i)
|
x
|
|
Rule 12h-3(b)(1)(ii)
|
¨
|
|
Rule 15d-6
|
¨
|
|
Rule 15d-22(b)
|
¨
|
Approximate number of holders of record
as of the certificate or notice date: One (1)
Pursuant to the requirements
of the Securities Exchange Act of 1934, NeuroDerm Ltd. has caused this certification/notice to be signed on its behalf by the undersigned
duly authorized person.
|
|
|
|
NeuroDerm Ltd.
|
|
|
|
|
Date: October 30, 2017
|
|
|
|
By:
|
|
/s/ Oded S. Lieberman
|
|
|
|
|
Name:
|
|
Oded S. Lieberman
|
|
|
|
|
Title:
|
|
Chief Executive Officer and Director
|
NEURODERM LTD. (NASDAQ:NDRM)
Historical Stock Chart
From Aug 2024 to Sep 2024
NEURODERM LTD. (NASDAQ:NDRM)
Historical Stock Chart
From Sep 2023 to Sep 2024